Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus Type 1 (HIV-1) Infection”

1,906 trials

Showing 20 of 1,906 results

Testing effectiveness (Phase 2)Ended earlyNCT00102778
What this trial is testing

GW873140 In Combination With Kaletra In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 175
Large-scale testing (Phase 3)Active Not RecruitingNCT05630755
What this trial is testing

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 514
Testing effectiveness (Phase 2)Study completedNCT00880698
What this trial is testing

Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers

Who this might be right for
HIV InfectionRotavirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 202
Testing effectiveness (Phase 2)UnknownNCT02648516
What this trial is testing

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients

Who this might be right for
Human Immunodeficiency VirusDisorder of Immune Reconstitution
Beijing 302 Hospital 20
Not applicableWithdrawnNCT01059084
What this trial is testing

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

Who this might be right for
HIVHIV Infections
University of Washington
Early research (Phase 1)Study completedNCT00326716
What this trial is testing

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Who this might be right for
HIV Infection
Bristol-Myers Squibb 69
Early research (Phase 1)Study completedNCT00252148
What this trial is testing

Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Who this might be right for
HIV Infection
International AIDS Vaccine Initiative 48
Testing effectiveness (Phase 2)Study completedNCT00004584
What this trial is testing

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00040274
What this trial is testing

DPC 817 in HIV-Infected Males

Who this might be right for
HIV Infections
Pharmasset 30
Large-scale testing (Phase 3)Study completedNCT00424814
What this trial is testing

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 105
Large-scale testing (Phase 3)Study completedNCT04223778
What this trial is testing

Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 672
Early research (Phase 1)Study completedNCT00001055
What this trial is testing

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06338826
What this trial is testing

Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses

Who this might be right for
HIV InfectionsHBV Coinfection
ANRS, Emerging Infectious Diseases 140
Large-scale testing (Phase 3)Study completedNCT00209313
What this trial is testing

Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon

Who this might be right for
HIV-1 and HSV-2 CoinfectionHIV Infections
Fred Hutchinson Cancer Center 40
Not applicableWithdrawnNCT05783388
What this trial is testing

Measuring the HIV-1 Reservoir During Cure Interventions Studies (MERCI)

Who this might be right for
Hiv
University Hospital, Ghent
Testing effectiveness (Phase 2)Looking for participantsNCT04648280
What this trial is testing

Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Who this might be right for
HIV Infections With Multi Drug Resistant Virus
PENTA Foundation 60
Not applicableNot Yet RecruitingNCT06913959
What this trial is testing

HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 220
Large-scale testing (Phase 3)Ended earlyNCT01145417
What this trial is testing

Pregabalin Trial In HIV Neuropathic Pain

Who this might be right for
HIV-1 InfectionNeuropathic Pain
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 217
Early research (Phase 1)Active Not RecruitingNCT05471076
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of Priming Regimens of 426c.Mod.Core-C4b and Optional Boost Regimen With HIV Trimer BG505 SOSIP.GT1.1 gp140, Both Adjuvanted With 3M-052-AF + Alum in Healthy, Adult Participants Without HIV

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 52
Large-scale testing (Phase 3)Study completedNCT01153217
What this trial is testing

Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density

Who this might be right for
HIV
Germans Trias i Pujol Hospital 54
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation